SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · IEX Real-Time Price · USD
1.130
+0.020 (1.80%)
Jul 22, 2024, 10:06 AM EDT - Market open

SLS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2004
Net Income
-35.81-37.34-41.3-20.7-16.84-27.95
Upgrade
Depreciation & Amortization
0.550.50.460.170.10
Upgrade
Share-Based Compensation
2.032.091.731.010.580.57
Upgrade
Other Operating Activities
3.193.3415.31-6.515.671.08
Upgrade
Operating Cash Flow
-30.04-31.41-23.81-26.02-10.42-17.64
Upgrade
Acquisitions
-3-5.5-4.5000
Upgrade
Investing Cash Flow
-3-5.5-4.5000
Upgrade
Share Issuance / Repurchase
30.0922.3524.0812.0738.4419.57
Upgrade
Other Financing Activities
-0.03-0.03----
Upgrade
Financing Cash Flow
30.0622.3224.0812.0738.4419.57
Upgrade
Net Cash Flow
-5.49-14.6-4.23-13.9528.031.93
Upgrade
Free Cash Flow
-30.04-31.41-23.81-26.02-10.42-17.64
Upgrade
Free Cash Flow Margin
---2380.90%-342.38%-548.26%-
Upgrade
Free Cash Flow Per Share
-0.67-1.13-1.23-1.68-1.31-6.89
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).